Drugs that target the mediator of nerve cell communication dopamine alleviate many of the symptoms of Parkinson's disease but not the gait disorders and falls that affect those with severe disease. New research indicates that drugs targeting nerve cells that communicate using the molecule acetylcholine in the PPN region of the brain might provide a way to alleviate these otherwise untreatable symptoms of Parkinson's disease.